NDC Package 0006-3856-02 Recarbrio

Imipenem Anhydrous,Cilastatin,And Relebactam Anhydrous Injection, Powder, For Solution - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
Package Description:
25 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE (0006-3856-01)
Product Code:
Proprietary Name:
Non-Proprietary Name:
Imipenem Anhydrous, Cilastatin, And Relebactam Anhydrous
Substance Name:
Cilastatin; Imipenem Anhydrous; Relebactam Anhydrous
Usage Information:
RECARBRIO is contraindicated in patients with a history of known severe hypersensitivity (severe systemic allergic reaction such as anaphylaxis) to any component of RECARBRIO.
11-Digit NDC Billing Format:
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2184142 - cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
  • RxCUI: 2184147 - Recarbrio 500 MG / 500 MG / 250 MG Injection
  • RxCUI: 2184147 - cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection [Recarbrio]
  • RxCUI: 2184147 - Recarbrio 1.25 GM Injection
  • Product Type:
    Human Prescription Drug
    Labeler Name:
    Merck Sharp & Dohme Llc
    Dosage Form:
    Injection, Powder, For Solution - A sterile preparation intended for reconstitution to form a solution for parenteral use.
    Administration Route(s):
  • Intravenous - Administration within or into a vein or veins.
  • Sample Package:
    FDA Application Number:
    Marketing Category:
    NDA - A product marketed under an approved New Drug Application.
    Start Marketing Date:
    Listing Expiration Date:
    Exclude Flag:
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 0006-3856-02?

    The NDC Packaged Code 0006-3856-02 is assigned to a package of 25 vial, single-dose in 1 carton / 20 ml in 1 vial, single-dose (0006-3856-01) of Recarbrio, a human prescription drug labeled by Merck Sharp & Dohme Llc. The product's dosage form is injection, powder, for solution and is administered via intravenous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 0006-3856 included in the NDC Directory?

    Yes, Recarbrio with product code 0006-3856 is active and included in the NDC Directory. The product was first marketed by Merck Sharp & Dohme Llc on January 06, 2020 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 0006-3856-02?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 0006-3856-02?

    The 11-digit format is 00006385602. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 4-4-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code